Herein, our findings have provided a new insight into the PKM2‐induced tumor glycolysis and angiogenesis that was potentiated by multiple protein–protein interactions mediated by FOXM1D, and suggest that FOXM1 may be a promising target for cancer therapeutics. The gene discussed is PKM; the disease is cancer.